Upregulated MicroRNA-185-3p Inhibits the Development of Hyperlipidemia in Rats

Conclusion: Upregulated miR-185-3p represses hyperlipidemia development via modulating MAML1 expression. This research provides novel therapeutic candidates for the treatment of hyperlipidemia.
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research